Advanced in Acute Myelomonocytic Leukemia

Roberto Cairoli

Milan, IT 
Advanced in Acute Myelomonocytic Leukemia
Milan, IT 
OverviewLocationsClinical Research

Overview

Roberto Cairoli practices in Milan, Italy. Mr. Cairoli is rated as an Advanced expert by MediFind in the treatment of Acute Myelomonocytic Leukemia. His top areas of expertise are Leukemia, Acute Myeloid Leukemia (AML), Thrombocytopenia, Bone Marrow Transplant, and Splenectomy.

His clinical research consists of co-authoring 110 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Milan, Italy
Other Locations
Ravenna, Italy
Como, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Prospective Evaluation of a Continuation Therapy With Midostaurin in Adult Patients With Core-binding Factor Leukemia and Integrated Genetic Analysis: a Multi-center Phase II Study
Prospective Evaluation of a Continuation Therapy With Midostaurin in Adult Patients With Core-binding Factor Leukemia and Integrated Genetic Analysis: a Multi-center Phase II Study
Enrollment Status: Terminated
Publish Date: February 25, 2025
Intervention Type: Drug
Study Drug: Midostaurin
Study Phase: Phase 2
Study Investigating Safety, Tolerability and Effectiveness of Venetoclax Add in Combination With Fludarabine, Cyratabine and Idarubicine in Induction of New Onset Non-M3 Acute Myelid Leukemia
Study Investigating Safety, Tolerability and Effectiveness of Venetoclax Add in Combination With Fludarabine, Cyratabine and Idarubicine in Induction of New Onset Non-M3 Acute Myelid Leukemia
Enrollment Status: Active_not_recruiting
Publish Date: April 10, 2024
Intervention Type: Drug
Study Drug: Venetoclax
Study Phase: Phase 2
View 1 Less Clinical Trial

110 Total Publications

Trends in GVHD Epidemiology, Prophylaxis and Management: The Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare (GITMO) GVHD24 Study.
Trends in GVHD Epidemiology, Prophylaxis and Management: The Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare (GITMO) GVHD24 Study.
Journal: American journal of hematology
Published: August 22, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Cairoli's expertise for a condition
ConditionClose
    View All 15 Advanced Conditions
    View All 21 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile